PLEKHM2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.590100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.510200E-02
Normal-vs-Stage2
6.276100E-02
Normal-vs-Stage3
8.203800E-02
Normal-vs-Stage4
8.509800E-02
Stage1-vs-Stage2
4.874400E-01
Stage1-vs-Stage3
9.272000E-01
Stage1-vs-Stage4
3.509000E-01
Stage2-vs-Stage3
4.987600E-01
Stage2-vs-Stage4
6.986200E-01
Stage3-vs-Stage4
4.357200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.197800E-02
Normal-vs-AfricanAmerican
1.877200E-01
Normal-vs-Asian
1.377970E-01
Caucasian-vs-AfricanAmerican
6.382400E-01
Caucasian-vs-Asian
9.712200E-01
AfricanAmerican-vs-Asian
7.296000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.933900E-02
Normal-vs-Female
9.186100E-02
Male-vs-Female
2.740400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.670200E-02
Normal-vs-Age(41-60Yrs)
1.340640E-01
Normal-vs-Age(61-80Yrs)
3.114500E-02
Normal-vs-Age(81-100Yrs)
1.475440E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.065600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.823600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.878600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.193800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.818000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.675400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.713900E-02
Normal-vs-Daily Drinker
4.274400E-02
Normal-vs-Weekly Drinker
1.044630E-01
Normal-vs-Occasional Drinker
7.602000E-02
Normal-vs-Social Drinker
1.804110E-02
Non Drinker-vs-Daily Drinker
3.593200E-01
Non Drinker-vs-Weekly Drinker
8.775600E-02
Non Drinker-vs-Occasional Drinker
2.138000E-01
Non Drinker-vs-Social Drinker
3.639600E-01
Daily Drinker-vs-Weekly Drinker
3.344400E-01
Daily Drinker-vs-Occasional Drinker
6.686800E-01
Daily Drinker-vs-Social Drinker
9.386000E-01
Weekly Drinker-vs-Occasional Drinker
4.727600E-01
Weekly Drinker-vs-Social Drinker
3.555200E-01
Occasional Drinker-vs-Social Drinker
7.255000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.781000E-01
Normal-vs-Grade 2
8.482200E-01
Normal-vs-Grade 3
8.329000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.453900E-02
Grade 1-vs-Grade 3
1.709200E-01
Grade 1-vs-Grade 4
7.781000E-01
Grade 2-vs-Grade 3
5.788600E-01
Grade 2-vs-Grade 4
8.482200E-01
Grade 3-vs-Grade 4
8.329000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.928300E-02
Normal-vs-NonDiabetic
6.488000E-02
Diabetic-vs-NonDiabetic
9.565800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.917600E-02
Normal-vs-NoPancreatitis
6.954300E-02
Pancreatitis-vs-NoPancreatitis
8.511800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.660070E-02
Normal-vs-N1
8.033800E-02
N0-vs-N1
3.021800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.344100E-03
Normal-vs-TP53-NonMutant
1.884470E-02
TP53-Mutant-vs-TP53-NonMutant
7.512000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
